A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
N/A
Rheumatoid Arthritis (RA) is an inflammatory disease of the joints characte...
Status
Completed
Location
Inje University - Busan Paik Hospital /ID# 259143
Start Date
2021-01-26
Trial ID
NCT04541810
Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)
N/A
Atopic dermatitis (AD) is a common, chronic, inflammatory skin disease with...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07741838
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
PHASE2
The primary objective is to compare the safety and efficacy of multiple dos...
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
PHASE3
The objective of this study is to evaluate the efficacy and safety of upada...
Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study.
PHASE2
Lichen planus (LP) is a common immune-mediated skin disease with a prevalen...
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
N/A
Atopic dermatitis (AD) is a skin condition that may cause a rash and itchin...